Data abstractedfrom ACC15 AbstractA1363, PooledSafetyandAdverseEventsinNine Randomized,
Placebo-Controlled,Phase 2andPhase...
Upcoming SlideShare
Loading in …5
×

Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.

3,953 views

Published on

Data abstracted from ACC15 Abstract A1363. JACC March 17, 2015, Volume 65, Issue 10S.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
3,953
On SlideShare
0
From Embeds
0
Number of Embeds
3,082
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.

  1. 1. Data abstractedfrom ACC15 AbstractA1363, PooledSafetyandAdverseEventsinNine Randomized, Placebo-Controlled,Phase 2andPhase 3 Clinical Trialsof Alirocumab. J Am Coll Cardiol. 2015; 65(10_S). doi: 10.1016/S0735-1097(15)61363-8. Alirocumab Placebo N=2482 N=1277 Adverse events,%(n) Anytreatment-emergent diabetesorworseningof preexistingdiabetes 3.4 (83) 3.1 (40) Otherclinical laboratorydata. Week52 change frombaseline. N=2318 N=1174 Fastingglucose,mmol/L,mean (SD) 0.16 (1.52) 0.13 (1.64) HemoglobinA1c%,mean(SD) 0.10 (0.66) 0.07 (0.54)

×